Announcements Trials
Browse Landscape

Phase

Phase 2 29Phase 1/2 6Phase 3 4Phase 1 4Phase NA 2

Status

Unknown 2Terminated 1Completed 1

Sponsor Class

OTHER 2NIH 2

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Myeloid 4

Conditions

Leukemia, Myeloid, Acute 19Leukemia 16Myelodysplastic Syndromes 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Neuroblastoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Multiple Myeloma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Congenital Abnormalities 3Sarcoma, Ewing 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, B-Cell, Marginal Zone 2Lymphoma 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Lymphocytic, Chronic, B-Cell 2Graft vs Host Disease 2Burkitt Lymphoma 2Anemia, Refractory, with Excess of Blasts 2Sarcoma 1Recurrence 1

Interventions

Imatinib Mesylate 28nilotinib 21Cytarabine 8Cyclophosphamide 8Methotrexate 7Peripheral Blood Stem Cell Transplantation 6Interferon-alpha 6Hydroxyurea 6bosutinib 5asciminib 5Whole-Body Irradiation 5Mycophenolic Acid 5Tacrolimus 4Dasatinib 4Busulfan 4peginterferon alfa-2a 3fludarabine phosphate 3fludarabine 3Radiotherapy 3Cyclosporine 3sargramostim 2ponatinib 2Sirolimus 2Idarubicin 2Etoposide 2BID protein, human 2thymoglobulin 1peginterferon alfa-2b 1pegaspargase 1olverembatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Busulfan × Clear all
NCT01366612 2026-04-03

FLUBUTBI

Hackensack Meridian Health

Phase 3 Terminated
53 enrolled 11 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute

NCT00025402 2013-12-18

Chemotherapy and Biological Therapy With or Without Bone Marrow or Peripheral Stem Cell Transplant in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
1,000 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00002771 2013-08-02

Chemotherapy, Interferon, and Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
750 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00002789 2010-03-30

Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 3 Completed
100 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡